Your browser doesn't support javascript.
loading
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gore, Martin; Hackshaw, Allan; Brady, William E; Penson, Richard T; Zaino, Richard; McCluggage, W Glenn; Ganesan, Raji; Wilkinson, Nafisa; Perren, Timothy; Montes, Ana; Summers, Jeffrey; Lord, Rosemary; Dark, Graham; Rustin, Gordon; Mackean, Melanie; Reed, Nicholas; Kehoe, Sean; Frumovitz, Michael; Christensen, Helen; Feeney, Amanda; Ledermann, Jonathan; Gershenson, David M.
Afiliación
  • Gore M; Royal Marsden NHS Foundation Trust, London, UK.
  • Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK. Electronic address: a.hackshaw@ucl.ac.uk.
  • Brady WE; Roswell Park Comprehensive Cancer Centre, Buffalo, USA.
  • Penson RT; Massachusetts General Hospital, Boston, USA.
  • Zaino R; Penn State Health Milton S. Hershey Medical Centre, PA, USA.
  • McCluggage WG; Dept of Pathology, Belfast Health & Social Care Trust, Belfast, UK.
  • Ganesan R; Birmingham Women's Hospital, Birmingham, UK.
  • Wilkinson N; University College London Hospitals NHS Foundation Trust, London, UK.
  • Perren T; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Montes A; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Summers J; Maidstone and Tunbridge Wells NHS Foundation Trust, Kent, UK.
  • Lord R; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Dark G; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Rustin G; Mount Vernon Cancer Centre, Middlesex, UK.
  • Mackean M; Edinburgh Cancer Centre, Edinburgh, UK.
  • Reed N; Beatson Oncology Centre, Glasgow, UK.
  • Kehoe S; Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK.
  • Frumovitz M; The University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Christensen H; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Feeney A; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Ledermann J; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Gershenson DM; The University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
Gynecol Oncol ; 153(3): 541-548, 2019 06.
Article en En | MEDLINE | ID: mdl-31005287
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Quísticas, Mucinosas y Serosas / Carcinoma Epitelial de Ovario / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Quísticas, Mucinosas y Serosas / Carcinoma Epitelial de Ovario / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido